Sangon Biotech: difference between revisions
Diff·revision 19 → 20·16:25, 11 Oct 2025
Difference between revision 19 and revision 20 of Sangon Biotech. 7 lines changed; the page grew by 1,024 bytes.
| Revision 19 — 11:48, 17 Sep 2025 StubSorterBot (talk) bot: sort category members 12,400 bytes +261 | Revision 20 — 16:25, 11 Oct 2025 A1c_Alder (talk) state the city and province of the registered address 13,424 bytes +1,024 | ||
|---|---|---|---|
| 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} |
| 93 | 93 | ||
| + | 94 | Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} | |
| + | 95 | ||
| + | 96 | == Notability and coverage == | |
| + | 97 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} | |
| + | 98 | ||
| + | 99 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | |
| + | 100 | ||
| 94 | == References == | 101 | == References == |
| 95 | {{reflist}} | 102 | {{reflist}} |